Acute caffeine treatment increases extracellular nucleotide hydrolysis from rat striatal and hippocampal synaptosomes

Neurochemical Research

Volumn 28, Issue 8, 2003, Pages 1249-1254

  Souza da Silva, Rosane ^a   Bruno, Alessandra Nejar ^a   Oliveira Battastini, Ana Maria ^a   Freitas Sarkis, João José ^a   Rizzato Lara, Diogo ^b   Bonan, Carla Denise ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

5 nucleotidase; Adenosine; Caffeine; Ecto nucleotidases ; NTPDases; Theophylline

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; APYRASE; CAFFEINE; ECTO 5' NUCLEOTIDASE; PSYCHOSTIMULANT AGENT; THEOPHYLLINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; HYDROLYSIS; IN VITRO STUDY; LOCOMOTION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; SLEEP DISORDER;

ADENINE NUCLEOTIDES; ANIMALS; CAFFEINE; EXTRACELLULAR SPACE; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; SYNAPTOSOMES; THEOPHYLLINE;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0038047531     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024292831762     Document Type: Article

References (36)

1. Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A., and Zvartau, E. E. 1999. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51:83-133.
2. Griffiths, R. R. and Chausmer, A. L. 2000. Caffeine as a model drug of dependence: Recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome and caffeine negative reinforcement. Nihon Shinkei Seishin Yakurigaku Zasshi. 20:223-231.
3. Dunwiddie, T. V. and Masino, S. A. 2001. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24:31-55.
4. Fredholm, B. B., Ijzerman, A. P., Jacobson, K. A., Klotz, K. N., and Linden J. 2001. International Union of Pharmacology, XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:527-552.
5. Sebastião, A. M. and Ribeiro, A. 2000. Fine tuning neuromodulation by adenosine. TIPS. 21:341-346.
6. Ferré, S., Popoli, P., Giménez-Llort, L., Rimondini, R., Müller, C. E., Strömberg, I., Ogren, S. O., and Fluxe, K. 2001. Adenosine/dopamine interaction: Implications for the treatment of Parkinson's disease. Parkinsonism. Relat. Disord. 7:235-241.
7. Jacobson, K. A., Nikodijevic, O., Padgett, W. L., Gallo-Rodriguez, C., Maillard, M., and Daly, J. W. 1993. 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett. 323(1-2):141-144.
8. 1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats. J. Neurochem. 82:625-634.
9. 2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 347:407-414.
10. Svenningsson, P., Nomikos, G. G., and Fredholm, B. B. 1999. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J. Neurosci. 19:4011-4022.
11. Cunha, R., Almeida, T., and Ribeiro, J. A. 2001. Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats. J. Neurochem. 76:372-382.
12. Zimmermann, H. 2001. Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev. Res. 52: 44-56.
13. Zimmermann, H. and Braun, N. 1999. Ecto-nucleotidases: Molecular structures, catalytic properties, and functional roles in the nervous system. Prog. Brain Res. 120:371-385.
14. Bonan, C. D., Schetinger, M. R., Battastini, A. M. O., and Sarkis, J. J. 2001. Ectonucleotidases and synaptic plasticity: Implications in physiological and pathological conditions. Drug Dev. Res. 52:57-65.
15. 2+-ATPase activity of synaptosome fraction and synaptosomal membranes from different areas of rat brain. Int. J. Biochem. 15:163-165.
16. (+)-ATPase in rat pancreatic islets. J. Biol. Chem. 265:3936-3939.
17. Fredholm, B. B., Hedqvist, P., and Vernet, L. 1978. Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5′-nucleotidase and adenosine deaminase. Biochem. Pharmacol. 27:2845-2850.
18. Tsuzuki, J. and Newburgh, R. W. 1975. Inhibition of 5′-nucleotidase in rat brain by methylxanthines. J. Neurochem. 25:895-896.
19. Fredholm, B. B. and Lindgren, E. 1983. Inhibition of soluble 5′-nucleotidase from rat brain by different xanthine derivatives. Biochem. Pharmacol. 32:2832-2834.
20. Jensen, M. H. and Jacobsen, J. B. 1987. The influence of theophylline and phenobarbital on rat brain 5′-nucleotidase. Acta Neurol. Scand. 76:46-49.
21. Cunha, R. 2001. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors. Neurochem. Int. 38:107-125.
22. Nagy, A. K. and Delgado-Escueta, A. V. 1984. Rapid preparation of synaptosomes from mammalian brain using a non toxic isoosmotic gradient (Percoll). J. Neurochem. 43:1114-1123.
23. Battastini, A. M. O., Rocha, J. B. T., Barcellos, C. K., Dias, R. D., and Sarkis, J. J. F. 1991. Characterization of an ATP diphosphohydrolase (EC 3.6.1.5) in synaptosomes from cerebral cortex of adult rats. Neurochem. Res. 16:1303-1310.
24. Heymann, D., Reddington, M., and Kreutzbeg, G. W. 1984. Subcellular localization of 5′-nucleotidase in rat brain. J. Neurochem. 43:971-978.
25. +2-ATPase activity. Anal. Biochem. 157:375-380.
26. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:218-254.
27. Jacobson, K. A., Von Lubitz, D. K., Daly, J. W., and Fredholm, B. B. 1996. Adenosine receptor ligands: Differences with acute versus chronic treatment. TIPS 17:108-113.
28. Ralevic, V. and Burnstock, G. 1998. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:413-492.
29. Kegel, B., Braun, N., Heine, P., Maliszewski, C. R., and Zimmermann, H. 1997. An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacol. 36:1189-200.
30. Lewis-Carl, S. and Kirley, T. L. 1997. Immunolocalization of the ecto-ATPase and ecto-apyrase in chicken gizzard and stomach: Purification and N-terminal sequence of the stomach ectoapyrase. J. Biol. Chem. 272:23645-23652.
31. Solinas, M., Ferre, S., You, Z. B., Karcz-Kubicha, M., Popoli, P., and Goldberg, S. R. 2002. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 22:6321-6324.
32. Boeck, C. R., Bronzatto, M. J., Souza, D. G., Sarkis, J. J., and Vendite, D. 2000. The modulation of ecto-nucleotidase activities by glutamate in cultured cerebellar granule cells. Neuroreport 11:709-712.
33. Bruno, A. N., Bonan, C. D., Wofchuk, S. T., Sarkis, J. J., and Battastini, A. M. 2002. ATP diphosphohydrolase (NTPDase 1) in rat hippocampal slices and effect of glutamate on the enzyme activity in different phases of development. Life Sci. 71: 215-225.
34. Aden, U., Herlenius, E., Tang, L., and Fredholm, B. B. 2000. Maternal intake has a minor effects on adenosine receptor ontogeny in the rat brain. Pediat. Res. 48:177-183.
35. 1 receptors in modulating extracellular adenosine levels. J. Pharmacol. Exp. Ther. 291: 76-80.
36. Fredholm, B. B. 1982. Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol. Scand. 115:283-286.